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validation in the collection, processing and clinical areas of the
program; d) identiﬁcation of benchmarks or goals for each key
measure/process; e) restructure of regularly occurring forum to
report and discuss QM activities including review and outcome
analysis of aggregate data on selected measures, identiﬁcation of
need for corrective actions and follow-up assessment of corrective
actions; f) mechanism for reporting deviations and complaints; and
g) the process for determining and maintaining competency of
personnel. DISCUSSION: QM activities should not be a regula-
tory exercise but result in meaningful improvement in a program’s
processes and outcomes. A clearly deﬁned and purposefully exe-
cuted QMP involving personnel from across our BMT program
helps to ensure the safety of the recipient and donor and ensure the
highest quality of care.
389
ANNUAL BLOOD AND MARROW TRANSPLANT PATIENT CEL-
EBRATRION IGNITES HOPE, STRENGTH AND RECOVERY
Laub, L.M.1 1Siteman Cancer Center, Barnes-Jewish Hospital/Wash-
ington University School of Medicine, St. Louis, MO.
Background and Purpose: A programmatic way of supporting
Hope, Strength and Recovery in Blood and Marrow Transplanta-
tion patients and their families is signiﬁcant in enhancing patient
care. The journey through transplantation and beyond is challeng-
ing for patients and caregivers. They navigate that journey with
strength, determination and with courage. In order to honor pa-
tients and families an annual patient and family celebration is held
at the Siteman Cancer Center of Barnes-Jewish Hospital.
Objectives: An annual event uniting patients who have been
transplanted only one or two months ago with those who where
transplanted 5, 10, or 20years ago can ignite hope and continued
recovery. The event is not only signiﬁcant for patients and families;
it is also signiﬁcant for the clinical physicians and team members
who provide the care by honoring their passion and commitment
to excellence.
Method: Post transplant patients and families, the referring
physician community, and clinical members of the inpatient and
outpatient BMT team are invited to the annual event. The event is
held at the Ritz Carlton where the atmosphere is truly spectacular.
The division chief addresses the audience at the start of the event
to recognize and honor the guests. Two transplant patients are
asked to speak at the event where they reﬂect back on their journey
and create inspiration. At the end of the evening, the celebration
unites an unrelated recipient with their donor for the very ﬁrst
time. This union captures the spirit of the night and the essence of
the journey that each patient takes.
Results: For the last 13 years the BMT division has held an
annual event to honor patients and family members. The celebra-
tion grew out of the monthly support group and blossomed into a
remarkable evening with over 500 in attendance each year. The
event allows the BMT program to reach out to patients and
families, to referring physicians, to the local community in an
effort to raise transplant awareness, and to the clinical team mem-
bers of the transplant service. The patient celebration brings joy
and enthusiasm, hugs and handshakes and ignites hope, strength
and recovery in all who attend.
390
AN EXPLORATIVE QUALITATIVE PILOT STUDY OF HOW PARENTS AND
CHILDREN EXPERIENCE THE TREATMENT WITH ALLOGENEIC STEM
CELL TRANSPLANTAITON (SCT) FOCUSING ON IMPROVEMENT OF
NURSING CARE
Laursen, H.B.1, Heilman, C.2 1Rigshospitalet, BMT-Unit 4042,
Copenhagen, Denmark; 2Rigshospitalet, JMC Paed Clinic II, 4064,
Copenhagen, Denmark.
Purpose: To examine what kind of psychological difﬁculties
Danish parents and children experiens during inpatient treatment
with allogeneic stem cell transplantation.
Methods: Semi-structured qualitative interviews with 6 mothers,
2 fathers and 3 children (age 11-15 years), representing the expe-
rience from seven SCT courses. Seven children were diagnosed
with 3 SAA, 2 ALL and 2 with immune deﬁciency disease. Time
from SCT to the interview was three months to 3frax;1;2 year
(average one year).
Results: The parents described interaction problems in relation
to 1. each other 2. the child undergoing SCT 3. other children in
the family and 4. the nursing staff. The main problems were:
- Lack of continuity in relation to the nursing staff, resulting in
inconsistant information and conﬂicts between children, parents
and nursing staff. It raises emotions such as insecurity, nervousness
and uncertainty.
- Conﬂicts between child and parents related to nursing e.g.
administration of medicine and meeting the child’s needs for food
and liquid. This may raise feelings of frustration and powerlessness
in the parents.
- The feeling of isolation by the parents due to spending most of
their time with the child in a LAF isolation room during the 5-7
weeks transplant course. The feeling of isolation is shown by a
reduction in the parents social life and adult contact. This results in
1. an inappropriate focusing on the child’s well being e.g. lab
results 2. inability to exercise 3. the inability to be able to leave the
child’s room.
- Those parents, who have more than one child, have a feeling of
being divided between the SCT child’s needs and the needs of the
other children in the family.
Conclusion: the parents’ wish to have: 1. a nursing team 2.
consistant information 3. help to handle and solve conﬂicts 4. the
possibility to leave the isolation room 5. the ability to exercise and
6. focus on the entire families situation and not only the SCT
childs problems.
391
HEALTH, PERFORMANCE AND PSYCHOSOCIAL ADJUSTMENT OF
HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN TEENAGERS
Lee, J.H.1, Kim, K.S.1, Choi, S.E.1, Bok, G.N.1, Lee, S.Y.1 1St. Mary’s
Hospital Catholic HSCT Center, Seoul, Korea.
This study invesgated health , performance and psychosoical
adjustment of post Haematopoetic Stem Cell Transplantation(H-
SCT) in teenagers for using basal data of rehabilitation and return
to normal life after HSCT. Most of pediatric patients are suffering
from a high degree of depression, anxiety and lowered self-esteem
due to painful invasive treatment for high dose chemotherapy,
radiation therapy and admission. HSCT Survivors have experi-
enced physical weakness, loneliness and isolation as well as physical
symptoms. Especially, the psychosocial aspect of children after
HSCT is very important in health, performance and psychosocial
adjustment.
We studied 63 teenagers who are 12-17 years old at least 100
days after HSCT. We used Nine symptom checklist of EORTC
(European Organization for Research and Treatment of cancer
Therapy) QOL-C30; fatigue, nausea and vomiting, pain, dyspnea,
insomnia, loss of appetite, constipation, diarrhea and ﬁnancial
difﬁculties, Lansky scale (Physical performance) and K-CBCL
(Korea-child behavior Checklist); Social competence scale, Behav-
ior problem scale.
The general characteristics were male 38 (60.3%), female 25
(39.7%), and median age 14.1years old( SD 1.53) .The diagnosis
were AML 23 (36.5%), ALL 18 (28.6%) and SAA 16(25.4%). The
type of transplantation were sibling allogeneic SCT 30 (47.6%),
unrelated SCT 25 (39.7%), autologous SCT 3 (4.8%), Cord 2
(3.1%) and FMM 3(4.8%). In Nine symptom checklist of EORTC,
fatigue (31.7) was the highest and then ﬁnancial difﬁculties (27.1)
and poor appetites (8.5). Eighty to one hundred Lansky score
which is the performance status scale was 53(91.4%). When both
of teenagers compare with standard group, their studying compe-
tence is lower but their socialization and total social competence
are comparatively high.
In conclusion, the major health problems of teenagers(12-17
years old) were fatigue and ﬁnancial difﬁculties after HSCT. How-
ever, the physical performance competence was affected to main-
tain active life. The psychosocial adjustment was high males and
females. However, the total behavior problem scale of females was
very high. We suggest focus on health and psychosocial issues of
teenagers and need to nursing intervention for them.
Transplant Nursing 141
 Social competence scale and Behavior problem scale of 1217 years
old
Male
12-17
(N 38)
Mean  SD
Standard of
Male
Mean  SD
Female
12-17
(N 25)
Mean  SD
Standard of
Female
Mean  SD
< Social
competence
>
Socialization 5.63  2.08 5.48  1.39 6.09  1.80 5.55  1.29
Studying
competence 3.60  0.88 3.83  0.77 3.78  0.77 3.84  0.70
Total Social
competence 9.33  2.64 9.31  1.69 10.13  2.05 9.39  1.58
< Behavior
problems >
Withdrawan 2.92  2.47 2.51  2.60 3.48  3.15 2.81  2.86
Somatic
Complaints 3.42  3.46 2.11  2.35 2.56  2.70 2.64  2.73
Anxious /
Depressed 4.13  3.36 3.31  3.47 5.84  4.65 4.18  4.08
Social Problems 3.47  2.79 1.93  2.19 3.00  2.19 1.90  2.09
Thought
Problems 1.07  1.34 0.83  1.31 1.52  1.32 0.80  1.41
Attention
Problems 4.13  2.80 4.25  3.43 4.76  3.21 3.97  3.30
Delinquent
Behavior 0.97  1.07 1.64  2.10 1.36  1.43 1.20  1.94
Aggressive
Behavior 5.21  3.89 5.36  5.30 6.92  3.49 5.90  5.07
Internalizing
Problems 10.23  6.90 7.80  6.98 11.48  8.38 9.37  8.11
Externalizing
Problems 6.18  4.35 7.00  6.63 8.28  4.55 7.10  6.47
Total Behavior
Promblems 28.97  16.50 25.73  20.63 32.64  16.73 26.83  21.72
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FUNDAMENTAL NURSING RESPONSIBILITIES IN MESENCHYMAL STEM
CELL INFUSION
Maldonado, M.1, Kebriaei, P.1, Granada, M.L.A.1, Szewczyk, N.1
1MD Anderson Cancer Center, Houston, TX.
Prevention and treatment of graft versus host disease (GVHD)
continues to be a challenge in the ﬁeld of Stem Cell Transplanta-
tion and Cellular Therapy (SCTCT). It may take multidrug ther-
apy with different mechanisms to control GVHD. Mesenchymal
Stem Cell (MSC) infusion is a new form of cellular therapy, which
may be potentially efﬁcacious in the treatment of GVHD. MSC
have the unique capability of differentiating into various tissues,
and can help in the repair process necessary in GVHD. These are
cells obtained in the adult bone marrow that may assist to control
how the immune system responds to foreign substances and nur-
ture the growth of new blood cells in the bone marrow. Finally, it
has immunomodulatory effects that are essential in treating
GVHD.
SCTCT nurses play a vital role in managing the care of patients
with GVHD. It is imperative that they have a strong knowledge
base of the accountabilities that surround them when involved in
the care of a patient receiving MSC. Close monitoring for possible
toxicities and serious adverse effects pre-, during and post infu-
sions, and proper documentation of assessments and ﬁndings, are
important as well. Upon understanding such, this will aid them to
immediately identify complications and relay accurate ﬁndings to
the physicians. Patient teaching plays an enormous role in the
administration of MSC because a well- informed patient is able to
comprehend their treatment, therefore, being proactive with their
care.
The tool developed to assist SCTCT nurses to identify the
standard procedures, such as pre-printed orders, the nursing re-
sponsibilities pre, during and post transfusion of MSC and a case
study will be presented. Consideration to incorporate this infor-
mation into annual competency check is being discussed.
393
THE ROLE OF IMMUNOGLOBULIN IN HEMATOPOIETIC STEM CELL
TRANSPLANTATION
Martin, A.1, Neumann, J.1 1The University of Texas M.D. Anderson
Cancer Center, Houston, TX.
Topic/Purpose:
It is critical to be knowledgeable about the indications, mecha-
nisms of action (MOA), and administration of medications and
treatments delivered in order to educate patients, eliminate med-
ication errors, and watch for harmful side effects. Intravenous
Immunoglobulin (IVIg) is a complex drug administered frequently
by nurses to certain patients receiving a hematopoietic stem cell
transplant (HSCT) as a standard of care for infection prevention,
and for other, lesser-known uses. In conversations with staff nurses
and new graduate nurses, a serious need has been identiﬁed to
educate nurses about the indications, MOA, and administration of
IVIg to ensure patient safety and improve nursing knowledge.
Intervention:
A presentation will be offered to nurses working with HSCT
patients exploring the current uses and indications of IVIG, how it
works, precautions for administration, and investigational uses.
Discussion:
Infection is the number one complication in patients receiving a
HSCT. Approximately half of all the patients receiving unrelated
donor stem cells develop at least one major, life-threatening infec-
tion post-transplant. IVIg is an infusion frequently used in patients
to help prevent or reduce the occurrence of these infections.
Immunoglobulins are antibodies found in the blood serum that
play a key role in identifying and destroying harmful foreign bodies
or antigens. These antibodies are subject to myelosuppressive
agents such as high-dose chemotherapy or immunosuppressants
after transplantation. IVIg is given to these patients to replace and
supplement the immunoglobulin deﬁciency. Although there is
some controversy surrounding its use, studies have suggested that
regular supplementation in these patients help prevent major in-
fections.
There are multiple issues related to the administration of IVIg. It
is derived from human blood products, therefore patients are at
risk for reactions during infusion. Nurses must be aware of all
possible reactions and monitor the patients during administration.
Evaluation:
Intravenous Immunoglobulin competency for nursing staff and
post testing for effectiveness is being developed.
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MORE THAN MY MARROW: DEVELOPMENT AND IMPLEMENTATION OF
A HEMATOPOIETIC STEM CELL DONOR RECOGNITION PROGRAM
McMullin, B.1, Sorensen, S.1, Choroszy, M.1, Carstens, K.1 1M.D.An-
derson Cancer Center and Children’s Cancer Hospital, Houston, TX.
Although alternative stem cell sources have expanded the hema-
topoietic stem cell transplant (HSCT) repertoire, a signiﬁcant
number of HSCT recipients still receive stem cells from related
donors. Related donors are frequently minor or adult-aged sib-
lings, but parents, children and other relatives of recipients may be
called upon to donate. Most donors are altruistic, but nonetheless
feel tremendous pressure to donate and can experience distress. Up
to half of the donors may face difﬁculties, which include sleep
disturbances, behavior problems, and poor academic achievement.
Feelings of resentment and guilt are commonly expressed. Pre-
donation ambivalence, donor’s perception of the adequacy of in-
formation provided, donor’s participation in the decision to do-
nate, and the quality of donor-recipient relationship are four
variables that have been associated with donor distress. Services
provided to donors are variable and often only related to immedi-
ate procedural concerns with little post-donation follow-up. Given
the frequent and signiﬁcant related donor and potential donor
distress, prophylactic services should be implemented to assist
donors with not only the procedural and physical issues but also the
psychosocial issues. Approximately 300 related HSCT donors are
chosen annually at our institution. Such prophylactic service pro-
vision is currently absent for the adult-aged related donors, and is
limited for minor-aged related donors to the obtaining of assent
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